Simcere 31
November 16, 2025 — Simcere Pharmaceutical Group (02096.HK) announced today that the National Medical Products Administration (NMPA) of China has appr...
November 10, 2026 — Simcere Pharmaceutical Group (02096.HK) announced today that SIM0725, its proprietary long-acting antagonist monoclonal antibody t...
Shanghai, China, 9 November 2026 – Simcere Pharmaceutical Group Ltd. (“Simcere”) (HKEX: 2096) today announced that SIM0709, a TL1A/IL-23p19 bispecific...
November 6, 2026 — Simcere Pharmaceutical Group (02096) announced today that the New Drug Application (NDA) for zemprocitinib—an orally administered, ...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions